Bilcare
- Market cap
- ₹ 198 Cr.
- P/E
- 10x
- P/B
- 1.02x
- 52-week range
- 51.62 – 113
- ROE
- 2%
- ROCE
- 6%
- Dividend yield
- 0%
- Debt / equity
- 3.15
- Sector
- Healthcare Services
- Industry
- Healthcare Research, Analytics & Technology
- Listed on
- NSE, BSE
About
Bilcare Limited is an India-based company. The Company is engaged in the business of Pharmaceutical Packaging, Global Clinical Services, and Research and Development (R&D) services. It has a single operating segment, namely Pharma Packaging Research Solutions. The Company offers a range of Pharma Packaging solutions, namely Blister Films, Blister Foils, Lidding Foils, Child-resistant (CR) Foils, and Laminations. Its R&D services include Formulation stability studies, Blister / Foil design & development, Pharma brand innovation, Analytical research & market study, and Packaging trials & audit. The Company has five subsidiaries, namely Bilcare GCS Limited, Bilcare Inc., Bilcare GCS Inc., Bilcare GCS Ireland Limited, Bilcare Pharma Solutions Limited, and Caprihans India Limited. Its annual manufacturing capacity is approximately 50000 tons. The Company has manufacturing facilities in Nashik, Pune, and Thane.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Healthcare Research, Analytics & Technology: 11 companies →Bilcare against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)10 against a typical 34.2: cheaper than most peers (1st = cheapest).2nd of 11
- Sales growth+21.5% against a typical +16.4% from a year earlier.5th of 10
- Share price, 3 months+39.9% against a typical −13%.1st of 11
- Size₹ 197.8 Cr. market value against a typical ₹ 197.8 Cr. (1st = largest).6th of 11
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 190 | 175 | 200 | 194 | 202 | 198 | 194 | 186 | 178 | 181 | 188 | 226 |
| Expenses | 173 | 158 | 208 | 175 | 194 | 187 | 186 | 175 | 175 | 168 | 171 | 189 |
| Operating Profit | 17 | 17 | −8 | 19 | 8 | 11 | 8 | 11 | 3 | 13 | 17 | 37 |
| OPM % | 9% | 10% | −4.1% | 10% | 3.8% | 5% | 4% | 6% | 1.9% | 7% | 9% | 16% |
| Other Income | 1 | 4 | 9 | 4 | −6 | −6 | 21 | 6 | 4 | 3 | 12 | 0 |
| Interest | 20 | 21 | 23 | 21 | 24 | 19 | 19 | 19 | 19 | 17 | 18 | 18 |
| Depreciation | 10 | 11 | 13 | 12 | 11 | 12 | 5 | 12 | 12 | 5 | 5 | 4 |
| Profit before tax | −13 | −10 | −35 | −10 | −33 | −27 | 6 | −13 | −24 | −6 | 7 | 15 |
| Tax % | −5% | 34% | −44% | 55% | −10% | −40% | −119% | −25% | −1% | 3% | −13% | −1% |
| Net Profit | −12 | −14 | −20 | −15 | −30 | −16 | 12 | −10 | −23 | −6 | 8 | 15 |
| EPS in Rs | −3.22 | −2.91 | −4.63 | −2.71 | −6.81 | −3.04 | 7.47 | −1.61 | −5.25 | 0.41 | 5.68 | 5.39 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- −12%
- 5 Years
- 3%
- 3 Years
- −9%
- TTM
- −1%
- 10 Years
- −9%
- 5 Years
- 16%
- 3 Years
- 37%
- TTM
- 248%
- 10 Years
- 6%
- 5 Years
- 5%
- 3 Years
- 2%
- TTM
- —
- 10 Years
- −46%
- 5 Years
- −6%
- 3 Years
- −4%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Bilcare | ₹ 81.41 | ₹ 198 Cr. | 10x | 1x | 2% | — |
| EPL | ₹ 221.40 | ₹ 7,080 Cr. | 18.7x | 2.7x | 14.9% | 8.3% |
| AGI Greenpac | ₹ 685.25 | ₹ 4,436 Cr. | 12.7x | 1.9x | 15.6% | 13.2% |
| Xpro India | ₹ 970.00 | ₹ 2,281 Cr. | 166.7x | 4.3x | 2.8% | 3.9% |
| Uflex | ₹ 555.20 | ₹ 4,015 Cr. | 9.5x | 0.4x | 4.1% | 2.1% |
| TCPL Packaging | ₹ 3,842.10 | ₹ 3,489 Cr. | 26.7x | 4x | 14.4% | 5.4% |
Management
- Mohan H. Bhandari
- Executive Chairman of the Board, Managing Director
- Deepa Mathur
- Chief Financial Officer
- Sagar R. Baheti
- Compliance Officer, Company Secretary
- Kavita Bhansali
- Executive Officer
Prices are delayed and for information only. Nothing on this page is investment advice.